Loading clinical trials...
Loading clinical trials...
This study is an observational study conducted prospectively under routine clinical setting for 1 year with about 700 patients diagnosed as Alzheimer's disease who will be treated by donepezil (Aricept) as monotherapy. The subjects will be recruited in the selected institutions of about 8 countries in Asia.
Participation in this study places no additional visit schedule, which will be determined by the investigator's judgment based on the disease progression of each subject. Investigators educate subjects to keep decided visit schedule, and collect the required information for case record from (CRF) on the visit.
Age
50 - 89 years
Sex
ALL
Healthy Volunteers
No
Beijing, China
Gangwon, China
Hong Kong, China
Nanjing, China
Shaanxi, China
Shanghai, China
Manila, Philippines
Singapore, Singapore
Busan, South Korea
Daegu, South Korea
Start Date
July 1, 2014
Primary Completion Date
August 1, 2016
Completion Date
August 1, 2016
Last Updated
December 28, 2016
532
ACTUAL participants
Lead Sponsor
Eisai Korea Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07033494